$3.92
0.06[1.55%]
At close: Apr 26
$3.92
0[0.00%]
After Hours: 4:02PM EDT
G1 Therapeutics
(NASDAQ:GTHX)Latest News for G1 Therapeutics Stock (NASDAQ:GTHX)
G1 Therapeutics Stock (NASDAQ: GTHX)
Categories: All
Friday, April 12, 2024
Monday, April 08, 2024
Wednesday, February 28, 2024
- G1 Therapeutics shares are trading higher after the company reported better-than-expected Q4 financial results.Benzinga Newsdesk - Feb 28, 2024, 1:00PM
- 12 Health Care Stocks Moving In Wednesday's Intraday SessionBenzinga Insights - Feb 28, 2024, 12:31PM
- Forecasting The Future: 5 Analyst Projections For G1 TherapeuticsBenzinga Insights - Feb 28, 2024, 12:01PM
- Needham Reiterates Buy on G1 Therapeutics, Maintains $12 Price TargetBenzinga Newsdesk - Feb 28, 2024, 11:45AM
- G1 Therapeutics Ended 2023 With Cash, Cash Equivalents, And Marketable Securities Of $82.2M, With Cash Runway Expected Into 2025Benzinga Newsdesk - Feb 28, 2024, 6:39AM
- G1 Therapeutics Q4 EPS $(0.21) Beats $(0.28) Estimate, Sales $14.87M Beat $13.08M EstimateBenzinga Newsdesk - Feb 28, 2024, 6:38AM
- Earnings Scheduled For February 28, 2024Benzinga Insights - Feb 28, 2024, 6:24AM
Tuesday, February 13, 2024
- G1 Therapeutics shares are trading lower after the company provided an interim update on the Phase 3 PRESERVE 2 trial of trilaciclib as the first-line treatment of metastatic triple-negative breast cancer.Benzinga Newsdesk - Feb 13, 2024, 1:34PM
- Why Is Breast Cancer-Focused G1 Therapeutics Stock Trading Lower Today?Vandana Singh - Feb 13, 2024, 1:24PM
- Why IPG Photonics Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionAvi Kapoor - Feb 13, 2024, 1:13PM
- 12 Health Care Stocks Moving In Tuesday's Intraday SessionBenzinga Insights - Feb 13, 2024, 12:31PM
- Why ZoomInfo Technologies Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving PremarketAvi Kapoor - Feb 13, 2024, 8:36AM
- Wedbush Maintains Outperform on G1 Therapeutics, Lowers Price Target to $4Benzinga Newsdesk - Feb 13, 2024, 8:27AM
- ZoomInfo Technologies To Rally Around 50%? Here Are 10 Top Analyst Forecasts For TuesdayAvi Kapoor - Feb 13, 2024, 8:08AM
- 12 Health Care Stocks Moving In Tuesday's Pre-Market SessionBenzinga Insights - Feb 13, 2024, 8:06AM
- Needham Maintains Buy on G1 Therapeutics, Lowers Price Target to $12Benzinga Newsdesk - Feb 13, 2024, 7:03AM
- Arista Networks Reports Q4 Results, Joins Teradata, Lattice Semiconductor And Other Big Stocks Moving Lower In Tuesday's Pre-Market SessionAvi Kapoor - Feb 13, 2024, 5:29AM
Monday, February 12, 2024
- 12 Health Care Stocks Moving In Monday's After-Market SessionBenzinga Insights - Feb 12, 2024, 4:30PM
- G1 Therapeutics Continues Phase 3 Trial Of Trilaciclib In Metastatic Triple Negative Breast Cancer Following Interim Analysis By Independent Data Monitoring CommitteeBenzinga Newsdesk - Feb 12, 2024, 4:06PM
- G1 Therapeutics Options Trading: A Deep Dive into Market SentimentBenzinga Insights - Feb 12, 2024, 1:45PM
Wednesday, January 24, 2024
Wednesday, December 13, 2023
Monday, December 11, 2023
Thursday, December 07, 2023
Wednesday, December 06, 2023
Tuesday, December 05, 2023
Wednesday, November 01, 2023
- Why Extreme Networks Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionLisa Levin - Nov 1, 2023, 1:59PM
- 12 Health Care Stocks Moving In Wednesday's Intraday SessionBenzinga Insights - Nov 1, 2023, 1:31PM
- G1 Therapeutics shares are trading lower after the company reported worse-than-expected Q3 revenue results and lowered its FY23 net revenue guidance.Benzinga Newsdesk - Nov 1, 2023, 11:11AM
- 12 Health Care Stocks Moving In Wednesday's Pre-Market SessionBenzinga Insights - Nov 1, 2023, 9:06AM
- Earnings Scheduled For November 1, 2023Benzinga Insights - Nov 1, 2023, 7:19AM
- G1 Therapeutics Lowers 2023 Net Revenue Guidance Due To Ongoing Shortage Of Platinum-Based Chemotherapy; Expects $44M-$47M (Prior View $50M-$60M) In COSELA Net RevenueBenzinga Newsdesk - Nov 1, 2023, 6:43AM
- G1 Therapeutics Q3 EPS $(0.35) Vs $(0.59) Last Year, Sales $12.30M Miss $14.23M EstimateBenzinga Newsdesk - Nov 1, 2023, 6:33AM